Table 2.
Control-1 |
FGFR1−/− | |||
---|---|---|---|---|
Vehicle | FGF23 | Vehicle | FGF23 | |
Serum phosphorus, mg/dl (pre- vs. post-FGF23 | 5.9±0.4 vs. 6.6±0.3 (n=11) | 5.8±0.3 vs. 4.2±0.4*(n=11) | 6.2±0.5 vs. 6.9±0.5 (n=8) | 5.6±0.3 vs. 5.2±0.5 (n=10) |
Serum FGF23, pg/ml | 137.8±3.4 (n=6) | 809.7±75.2‡ (n=6) | 247.0±32.7§ (n=8) | 941.1±184.3† (n=10) |
Serum 1,25(OH)2D3, pmol/l | 87.5±18.7 (n=8) | 11.8±0.7‡ (n=10) | 86.8±20.1 (n=6) | 11.3±0.8‡ (n=7) |
Serum PTH, pg/ml | 122.8±16.4 (n=13) | 107.8±27.4 (n=10) | 209.4±42.1§ (n=10) | 130.8±15.8 (n=8) |
Values are means ± SE; n = no. of mice.
P < 0.05, pre vs. post-FGF23.
P ≤ 0.005, vehicle vs. FGF23.
P ≤ 0.001, vehicle vs. FGF23.
P=0.05, control-1 vehicle vs. FGFR1−/− vehicle.